data_2XKU # _entry.id 2XKU # _audit_conform.dict_name mmcif_pdbx.dic _audit_conform.dict_version 5.371 _audit_conform.dict_location http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic # loop_ _database_2.database_id _database_2.database_code _database_2.pdbx_database_accession _database_2.pdbx_DOI PDB 2XKU pdb_00002xku 10.2210/pdb2xku/pdb PDBE EBI-44608 ? ? WWPDB D_1290044608 ? ? BMRB 17166 ? ? # loop_ _pdbx_database_related.db_name _pdbx_database_related.db_id _pdbx_database_related.content_type _pdbx_database_related.details PDB 1UQS unspecified 'THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL GLYCOLIPID' PDB 1BD2 unspecified 'COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201' PDB 2ESV unspecified 'STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX' PDB 2AK4 unspecified 'CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER PEPTIDE' PDB 1YPZ unspecified 'IMMUNE RECEPTOR' PDB 1IM3 unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX' PDB 1I7U unspecified 'CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-6V' PDB 1UXW unspecified 'CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS' PDB 1C16 unspecified 'CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/ DELTA T CELL LIGAND T22' PDB 1HSA unspecified 'HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA- B(ASTERISK)2705' PDB 2BNQ unspecified 'STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL VACCINES' PDB 1GZP unspecified 'CD1B IN COMPLEX WITH GM2 GANGLIOSIDE' PDB 2AXF unspecified 'THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED BY ITS MHC-BOUND CONFORMATION' PDB 1W72 unspecified 'CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3' PDB 2JCC unspecified 'AH3 RECOGNITION OF MUTANT HLA-A2 W167A' PDB 2BCK unspecified 'CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASEPEPTIDE' PDB 1DE4 unspecified 'HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRINRECEPTOR' PDB 2VLK unspecified 'THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN' PDB 1EXU unspecified 'CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR' PDB 1QRN unspecified 'CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A' PDB 2HLA unspecified 'HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW 68.1 (HLA-AW 68.1, HUMAN LEUCOCYTE ANTIGEN)' PDB 1MHE unspecified 'THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E' PDB 1IM9 unspecified 'CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELLINHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4' PDB 1EEZ unspecified 'CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TOGP2 PEPTIDE VARIANT(I2L/V5L)' PDB 1JHT unspecified 'CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ANONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A.' PDB 1QQD unspecified 'CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR' PDB 1QR1 unspecified 'POOR BINDING OF A HER-2/NEU EPITOPE (GP2 ) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE' PDB 1ZS8 unspecified 'CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5' PDB 1HLA unspecified 'HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 ( HLA-A2, HUMAN LEUCOCYTE ANTIGEN)' PDB 1I1Y unspecified 'CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y' PDB 1JGD unspecified 'HLA-B*2709 BOUND TO DECA-PEPTIDE S10R' PDB 1VGK unspecified 'THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITYCOMPLEX, H-2KD AT 2.0 A RESOLUTION' PDB 1UR7 unspecified 'MOLECULAR REFINEMENT OF ANTI-HLA-A2 USING LIGHT CHAIN SHUFFLING: A STRUCTURAL MODEL FOR HLA ANTIBODY BINDING' PDB 1AGE unspecified 'ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION)' PDB 2X89 unspecified 'STRUCTURE OF THE BETA2_MICROGLOBULIN INVOLVED IN AMYLOIDOGENESIS' PDB 1HHG unspecified . PDB 1S9X unspecified 'CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQA, IN COMPLEX WITH HLA-A2' PDB 1A9E unspecified 'DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS' PDB 1DUZ unspecified 'HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) INCOMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN' PDB 2X4U unspecified 'CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO HIV-1 PEPTIDE RT468-476' PDB 2CLR unspecified 'HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEXED WITH A DECAMERIC PEPTIDE FROM CALRETICULIN' PDB 3HLA unspecified 'HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2. 1 (HLA-A2.1 HUMAN LEUCOCYTE ANTIGEN)' PDB 2X4O unspecified 'CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120- 128' PDB 1M05 unspecified 'HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT' PDB 1TVB unspecified 'CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100( 209-217) BOUNDTO HUMAN CLASS I MHC HLA- A2' PDB 2V2W unspecified 'T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT' PDB 1ONQ unspecified 'CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE' PDB 2VLR unspecified 'THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN' PDB 2X4P unspecified 'CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A PHOTOCLEAVABLE PEPTIDE' PDB 2BVO unspecified ;STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG -TERM NON-PROGRESSION ; PDB 1A1N unspecified 'MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTYFROM THE NEF PROTEIN (75- 82) OF HIV1' PDB 1LP9 unspecified 'XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1' PDB 1ZSD unspecified 'CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBVANTIGEN EPLPQGQLTAY' PDB 1M6O unspecified 'CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLADPA*0201 PEPTIDE' PDB 1HHK unspecified . PDB 1HSB unspecified 'CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 ( LEUCOCYTE ANTIGEN)' PDB 1ZT4 unspecified 'THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA-GALACTOSYLCERAMIDE' PDB 1X7Q unspecified 'CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSIDPEPTIDE' PDB 1CE6 unspecified 'MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUSNUCLEOPROTEIN PEPTIDE' PDB 1PY4 unspecified 'BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOIDFORMATIONS' PDB 2J8U unspecified 'LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.' PDB 1SYV unspecified 'HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF' PDB 1SYS unspecified 'CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY' PDB 1OGT unspecified ;CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400-408 ) ; PDB 2X4T unspecified 'CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE' PDB 1CG9 unspecified 'COMPLEX RECOGNITION OF THE SUPERTYPIC BW6- DETERMINANT ONHLA-B AND-C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6' PDB 1P7Q unspecified 'CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR- 1, A HOST ANDVIRAL MHC RECEPTOR' PDB 1Q94 unspecified ;STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE ANCHOR RESIDUE ; PDB 1JNJ unspecified 'NMR SOLUTION STRUCTURE OF THE HUMAN BETA2- MICROGLOBULIN' PDB 1AGB unspecified 'ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION)' PDB 2D31 unspecified 'CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER' PDB 1XZ0 unspecified 'CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETICMYCOBACTIN LIPOPEPTIDE' PDB 1LDS unspecified 'CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2 -MICROGLOBULIN' PDB 1TVH unspecified 'CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2' PDB 1HHH unspecified . PDB 1XR8 unspecified 'CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3' PDB 2BSS unspecified 'CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705' PDB 1A1M unspecified 'MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDETYPDINQML FROM GAG PROTEIN OF HIV2' PDB 1E28 unspecified 'NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2 (TAFTIPSI)' PDB 2BVP unspecified ;STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG -TERM NON-PROGRESSION ; PDB 1XR9 unspecified 'CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3' PDB 2V2X unspecified 'T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.' PDB 2GJ6 unspecified 'THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRICACID) PEPTIDE' PDB 2X4R unspecified 'CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE' PDB 1EFX unspecified 'STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3' PDB 1QLF unspecified 'MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G' PDB 1TMC unspecified 'TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-AW68 COMPLEXED WITH A DECAMERIC PEPTIDE (EVAPPEYHRK)' PDB 2AV1 unspecified 'CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THEHEAVY CHAIN.' PDB 1QSF unspecified 'STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A' PDB 1DUY unspecified 'CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX PEPTIDE COMPLEX' PDB 1JGE unspecified 'HLA-B*2705 BOUND TO NONA-PEPTIDE M9' PDB 1KPR unspecified 'THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE HLA-E' PDB 2HJL unspecified 'CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE' PDB 1QEW unspecified ;HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201)COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATEDANTIGEN 3 (RESIDUES 271-279) ; PDB 1W0V unspecified 'CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF- RESPONSE FACTOR 1' PDB 1K5N unspecified 'HLA-B*2709 BOUND TO NONA-PEPTIDE M9' PDB 1AO7 unspecified 'COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201' PDB 2BNR unspecified 'STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL VACCINES' PDB 1XH3 unspecified 'CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERICPEPTIDES IN COMPLEX WITH HLA-B* 3501' PDB 2BST unspecified 'CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705' PDB 1MI5 unspecified 'THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBVPEPTIDE COMPLEX' PDB 2H26 unspecified 'HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINEAND SPACER' PDB 1A1O unspecified 'MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM' PDB 1S9Y unspecified 'CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQS, IN COMPLEX WITH HLA-A2' PDB 2A83 unspecified 'CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGONRECEPTOR (GR) PEPTIDE ( RESIDUES 412-420)' PDB 1AGF unspecified 'ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION)' PDB 1OGA unspecified 'A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.' PDB 2F8O unspecified 'A NATIVE TO AMYLOIDOGENIC TRANSITION REGULATED BY ABACKBONE TRIGGER' PDB 2X70 unspecified 'CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A PHOTOCLEAVABLE PEPTIDE' PDB 2CII unspecified 'THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY-INTERMEDIATE' PDB 1I7R unspecified 'CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1058' PDB 1JF1 unspecified 'CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ADECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A' PDB 2C7U unspecified 'CONFLICTING SELECTIVE FORCES AFFECT CD8 T- CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE.' PDB 1E27 unspecified 'NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1 (LPPVVAKEI)' PDB 2F74 unspecified 'MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33' PDB 1W0W unspecified 'CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF- RESPONSE FACTOR 1' PDB 1GZQ unspecified 'CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL' PDB 1UXS unspecified 'CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS' PDB 1AKJ unspecified 'COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 ANDTHE T CELL CORECEPTOR CD8' PDB 2HJK unspecified 'CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE' PDB 2VB5 unspecified 'SOLUTION STRUCTURE OF W60G MUTANT OF HUMAN BETA2-MICROGLOBULIN' PDB 1R3H unspecified 'CRYSTAL STRUCTURE OF T10' PDB 1AGD unspecified 'ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE)' PDB 2X4N unspecified ;CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO RESIDUAL FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT TREATMENT ; PDB 1EEY unspecified 'CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TOPEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)' PDB 1I7T unspecified 'CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-5V' PDB 1YDP unspecified '1.9A CRYSTAL STRUCTURE OF HLA-G' PDB 1I4F unspecified 'CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4- PEPTIDE COMPLEX' PDB 2VLL unspecified 'THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN' PDB 2BSR unspecified 'CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705' PDB 1B0R unspecified 'CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP' PDB 2VLJ unspecified 'THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN' PDB 2X4S unspecified 'CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN' PDB 1OF2 unspecified ;CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400-408 ) ; PDB 1B0G unspecified 'CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH BETA 2- MICROGLOBULIN AND HUMAN PEPTIDE P1049' PDB 1HHI unspecified . PDB 1QSE unspecified 'STRUCTURE OF HUMAN A6-TCR BOUND TO HLA- A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R' PDB 1A9B unspecified 'DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS' PDB 2AXG unspecified 'THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED BY ITS MHC-BOUND CONFORMATION' PDB 2BVQ unspecified ;STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG -TERM NON-PROGRESSION ; PDB 1AGC unspecified 'ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION)' PDB 1QVO unspecified ;STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE ANCHOR RESIDUE ; PDB 1HHJ unspecified ;HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317) ; PDB 1S9W unspecified 'CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC,IN COMPLEX WITH HLA-A2' PDB 1KTL unspecified 'THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE HLA-E' PDB 1A6Z unspecified 'HFE (HUMAN) HEMOCHROMATOSIS PROTEIN' PDB 2CIK unspecified ;INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450. ; PDB 1I1F unspecified 'CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y' PDB 2UWE unspecified 'LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION' PDB 2AV7 unspecified 'CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVYCHAIN.' PDB 2XKT unspecified 'PRION-LIKE CONVERSION DURING AMYLOID FORMATION AT ATOMIC RESOLUTION' PDB 2XKS unspecified 'PRION-LIKE CONVERSION DURING AMYLOID FORMATION AT ATOMIC RESOLUTION' BMRB 17166 unspecified . # _pdbx_database_status.status_code REL _pdbx_database_status.entry_id 2XKU _pdbx_database_status.deposit_site PDBE _pdbx_database_status.process_site PDBE _pdbx_database_status.SG_entry . _pdbx_database_status.recvd_initial_deposition_date 2010-07-12 _pdbx_database_status.pdb_format_compatible Y _pdbx_database_status.status_code_sf ? _pdbx_database_status.status_code_mr REL _pdbx_database_status.status_code_cs REL _pdbx_database_status.methods_development_category ? _pdbx_database_status.status_code_nmr_data REL # loop_ _audit_author.name _audit_author.pdbx_ordinal _audit_author.identifier_ORCID 'Eichner, T.' 1 ? 'Kalverda, A.P.' 2 ? 'Thompson, G.S.' 3 ? 'Homans, S.W.' 4 ? 'Radford, S.E.' 5 ? # loop_ _citation.id _citation.title _citation.journal_abbrev _citation.journal_volume _citation.page_first _citation.page_last _citation.year _citation.journal_id_ASTM _citation.country _citation.journal_id_ISSN _citation.journal_id_CSD _citation.book_publisher _citation.pdbx_database_id_PubMed _citation.pdbx_database_id_DOI primary 'Conformational Conversion During Amyloid Formation at Atomic Resolution.' Mol.Cell 41 161 172 2011 MOCEFL US 1097-2765 2168 ? 21255727 10.1016/J.MOLCEL.2010.11.028 1 'A Generic Mechanism of Beta2-Microglobulin Amyloid Assembly at Neutral Ph Involving a Specific Proline Switch.' J.Mol.Biol. 386 1312 ? 2009 JMOBAK UK 0022-2836 0070 ? 19452600 ? # loop_ _citation_author.citation_id _citation_author.name _citation_author.ordinal _citation_author.identifier_ORCID primary 'Eichner, T.' 1 ? primary 'Kalverda, A.P.' 2 ? primary 'Thompson, G.S.' 3 ? primary 'Homans, S.W.' 4 ? primary 'Radford, S.E.' 5 ? 1 'Eichner, T.' 6 ? 1 'Radford, S.E.' 7 ? # _cell.entry_id 2XKU _cell.length_a 1.000 _cell.length_b 1.000 _cell.length_c 1.000 _cell.angle_alpha 90.00 _cell.angle_beta 90.00 _cell.angle_gamma 90.00 _cell.Z_PDB 1 _cell.pdbx_unique_axis ? # _symmetry.entry_id 2XKU _symmetry.space_group_name_H-M 'P 1' _symmetry.pdbx_full_space_group_name_H-M ? _symmetry.cell_setting ? _symmetry.Int_Tables_number 1 # _entity.id 1 _entity.type polymer _entity.src_method man _entity.pdbx_description BETA-2-MICROGLOBULIN _entity.formula_weight 11153.478 _entity.pdbx_number_of_molecules 1 _entity.pdbx_ec ? _entity.pdbx_mutation ? _entity.pdbx_fragment 'IMMUNGLOBULIN, RESIDUES 27-119' _entity.details ? # _entity_name_com.entity_id 1 _entity_name_com.name 'BETA-2-MICROGLOBULIN FORM PI 5.3, DN6' # _entity_poly.entity_id 1 _entity_poly.type 'polypeptide(L)' _entity_poly.nstd_linkage no _entity_poly.nstd_monomer no _entity_poly.pdbx_seq_one_letter_code ;MIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHV TLSQPKIVKWDRDM ; _entity_poly.pdbx_seq_one_letter_code_can ;MIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHV TLSQPKIVKWDRDM ; _entity_poly.pdbx_strand_id A _entity_poly.pdbx_target_identifier ? # loop_ _entity_poly_seq.entity_id _entity_poly_seq.num _entity_poly_seq.mon_id _entity_poly_seq.hetero 1 1 MET n 1 2 ILE n 1 3 GLN n 1 4 VAL n 1 5 TYR n 1 6 SER n 1 7 ARG n 1 8 HIS n 1 9 PRO n 1 10 ALA n 1 11 GLU n 1 12 ASN n 1 13 GLY n 1 14 LYS n 1 15 SER n 1 16 ASN n 1 17 PHE n 1 18 LEU n 1 19 ASN n 1 20 CYS n 1 21 TYR n 1 22 VAL n 1 23 SER n 1 24 GLY n 1 25 PHE n 1 26 HIS n 1 27 PRO n 1 28 SER n 1 29 ASP n 1 30 ILE n 1 31 GLU n 1 32 VAL n 1 33 ASP n 1 34 LEU n 1 35 LEU n 1 36 LYS n 1 37 ASN n 1 38 GLY n 1 39 GLU n 1 40 ARG n 1 41 ILE n 1 42 GLU n 1 43 LYS n 1 44 VAL n 1 45 GLU n 1 46 HIS n 1 47 SER n 1 48 ASP n 1 49 LEU n 1 50 SER n 1 51 PHE n 1 52 SER n 1 53 LYS n 1 54 ASP n 1 55 TRP n 1 56 SER n 1 57 PHE n 1 58 TYR n 1 59 LEU n 1 60 LEU n 1 61 TYR n 1 62 TYR n 1 63 THR n 1 64 GLU n 1 65 PHE n 1 66 THR n 1 67 PRO n 1 68 THR n 1 69 GLU n 1 70 LYS n 1 71 ASP n 1 72 GLU n 1 73 TYR n 1 74 ALA n 1 75 CYS n 1 76 ARG n 1 77 VAL n 1 78 ASN n 1 79 HIS n 1 80 VAL n 1 81 THR n 1 82 LEU n 1 83 SER n 1 84 GLN n 1 85 PRO n 1 86 LYS n 1 87 ILE n 1 88 VAL n 1 89 LYS n 1 90 TRP n 1 91 ASP n 1 92 ARG n 1 93 ASP n 1 94 MET n # _entity_src_gen.entity_id 1 _entity_src_gen.pdbx_src_id 1 _entity_src_gen.pdbx_alt_source_flag sample _entity_src_gen.pdbx_seq_type ? _entity_src_gen.pdbx_beg_seq_num ? _entity_src_gen.pdbx_end_seq_num ? _entity_src_gen.gene_src_common_name HUMAN _entity_src_gen.gene_src_genus ? _entity_src_gen.pdbx_gene_src_gene ? _entity_src_gen.gene_src_species ? _entity_src_gen.gene_src_strain ? _entity_src_gen.gene_src_tissue ? _entity_src_gen.gene_src_tissue_fraction ? _entity_src_gen.gene_src_details ? _entity_src_gen.pdbx_gene_src_fragment ? _entity_src_gen.pdbx_gene_src_scientific_name 'HOMO SAPIENS' _entity_src_gen.pdbx_gene_src_ncbi_taxonomy_id 9606 _entity_src_gen.pdbx_gene_src_variant ? _entity_src_gen.pdbx_gene_src_cell_line ? _entity_src_gen.pdbx_gene_src_atcc ? _entity_src_gen.pdbx_gene_src_organ ? _entity_src_gen.pdbx_gene_src_organelle ? _entity_src_gen.pdbx_gene_src_cell ? _entity_src_gen.pdbx_gene_src_cellular_location ? _entity_src_gen.host_org_common_name ? _entity_src_gen.pdbx_host_org_scientific_name 'ESCHERICHIA COLI' _entity_src_gen.pdbx_host_org_ncbi_taxonomy_id 469008 _entity_src_gen.host_org_genus ? _entity_src_gen.pdbx_host_org_gene ? _entity_src_gen.pdbx_host_org_organ ? _entity_src_gen.host_org_species ? _entity_src_gen.pdbx_host_org_tissue ? _entity_src_gen.pdbx_host_org_tissue_fraction ? _entity_src_gen.pdbx_host_org_strain 'BL21(DE3)' _entity_src_gen.pdbx_host_org_variant ? _entity_src_gen.pdbx_host_org_cell_line ? _entity_src_gen.pdbx_host_org_atcc ? _entity_src_gen.pdbx_host_org_culture_collection ? _entity_src_gen.pdbx_host_org_cell ? _entity_src_gen.pdbx_host_org_organelle ? _entity_src_gen.pdbx_host_org_cellular_location ? _entity_src_gen.pdbx_host_org_vector_type PLASMID _entity_src_gen.pdbx_host_org_vector ? _entity_src_gen.host_org_details ? _entity_src_gen.expression_system_id ? _entity_src_gen.plasmid_name PET23A _entity_src_gen.plasmid_details ? _entity_src_gen.pdbx_description ? # _struct_ref.id 1 _struct_ref.db_name UNP _struct_ref.db_code B2MG_HUMAN _struct_ref.entity_id 1 _struct_ref.pdbx_seq_one_letter_code ? _struct_ref.pdbx_align_begin ? _struct_ref.pdbx_db_accession P61769 _struct_ref.pdbx_db_isoform ? # _struct_ref_seq.align_id 1 _struct_ref_seq.ref_id 1 _struct_ref_seq.pdbx_PDB_id_code 2XKU _struct_ref_seq.pdbx_strand_id A _struct_ref_seq.seq_align_beg 2 _struct_ref_seq.pdbx_seq_align_beg_ins_code ? _struct_ref_seq.seq_align_end 94 _struct_ref_seq.pdbx_seq_align_end_ins_code ? _struct_ref_seq.pdbx_db_accession P61769 _struct_ref_seq.db_align_beg 27 _struct_ref_seq.pdbx_db_align_beg_ins_code ? _struct_ref_seq.db_align_end 119 _struct_ref_seq.pdbx_db_align_end_ins_code ? _struct_ref_seq.pdbx_auth_seq_align_beg 7 _struct_ref_seq.pdbx_auth_seq_align_end 99 # _struct_ref_seq_dif.align_id 1 _struct_ref_seq_dif.pdbx_pdb_id_code 2XKU _struct_ref_seq_dif.mon_id MET _struct_ref_seq_dif.pdbx_pdb_strand_id A _struct_ref_seq_dif.seq_num 1 _struct_ref_seq_dif.pdbx_pdb_ins_code ? _struct_ref_seq_dif.pdbx_seq_db_name UNP _struct_ref_seq_dif.pdbx_seq_db_accession_code P61769 _struct_ref_seq_dif.db_mon_id ? _struct_ref_seq_dif.pdbx_seq_db_seq_num ? _struct_ref_seq_dif.details 'expression tag' _struct_ref_seq_dif.pdbx_auth_seq_num 6 _struct_ref_seq_dif.pdbx_ordinal 1 # loop_ _chem_comp.id _chem_comp.type _chem_comp.mon_nstd_flag _chem_comp.name _chem_comp.pdbx_synonyms _chem_comp.formula _chem_comp.formula_weight ALA 'L-peptide linking' y ALANINE ? 'C3 H7 N O2' 89.093 ARG 'L-peptide linking' y ARGININE ? 'C6 H15 N4 O2 1' 175.209 ASN 'L-peptide linking' y ASPARAGINE ? 'C4 H8 N2 O3' 132.118 ASP 'L-peptide linking' y 'ASPARTIC ACID' ? 'C4 H7 N O4' 133.103 CYS 'L-peptide linking' y CYSTEINE ? 'C3 H7 N O2 S' 121.158 GLN 'L-peptide linking' y GLUTAMINE ? 'C5 H10 N2 O3' 146.144 GLU 'L-peptide linking' y 'GLUTAMIC ACID' ? 'C5 H9 N O4' 147.129 GLY 'peptide linking' y GLYCINE ? 'C2 H5 N O2' 75.067 HIS 'L-peptide linking' y HISTIDINE ? 'C6 H10 N3 O2 1' 156.162 ILE 'L-peptide linking' y ISOLEUCINE ? 'C6 H13 N O2' 131.173 LEU 'L-peptide linking' y LEUCINE ? 'C6 H13 N O2' 131.173 LYS 'L-peptide linking' y LYSINE ? 'C6 H15 N2 O2 1' 147.195 MET 'L-peptide linking' y METHIONINE ? 'C5 H11 N O2 S' 149.211 PHE 'L-peptide linking' y PHENYLALANINE ? 'C9 H11 N O2' 165.189 PRO 'L-peptide linking' y PROLINE ? 'C5 H9 N O2' 115.130 SER 'L-peptide linking' y SERINE ? 'C3 H7 N O3' 105.093 THR 'L-peptide linking' y THREONINE ? 'C4 H9 N O3' 119.119 TRP 'L-peptide linking' y TRYPTOPHAN ? 'C11 H12 N2 O2' 204.225 TYR 'L-peptide linking' y TYROSINE ? 'C9 H11 N O3' 181.189 VAL 'L-peptide linking' y VALINE ? 'C5 H11 N O2' 117.146 # loop_ _pdbx_nmr_exptl.experiment_id _pdbx_nmr_exptl.conditions_id _pdbx_nmr_exptl.type _pdbx_nmr_exptl.solution_id 1 1 15NNOESY_CORR 1 2 2 HNCA 1 3 3 HNCACB 1 4 4 HSQC 1 5 5 D2O_AROCHSQC 1 6 6 HCCH_ARO 1 7 7 CBCACONH 1 8 8 C_TOCSY 1 9 9 HNCO 1 10 10 HNCOCA 1 11 11 HCCH_TOCSY 1 12 12 HCCH_COSY 1 13 13 HDA 1 14 14 HEA 1 15 15 AROCNOESY 1 16 16 D2O_CHSQC 1 17 17 D2O_CNOESY 1 # loop_ _pdbx_nmr_exptl_sample_conditions.conditions_id _pdbx_nmr_exptl_sample_conditions.temperature _pdbx_nmr_exptl_sample_conditions.pressure_units _pdbx_nmr_exptl_sample_conditions.pressure _pdbx_nmr_exptl_sample_conditions.pH _pdbx_nmr_exptl_sample_conditions.ionic_strength _pdbx_nmr_exptl_sample_conditions.ionic_strength_units _pdbx_nmr_exptl_sample_conditions.pH_units _pdbx_nmr_exptl_sample_conditions.temperature_units _pdbx_nmr_exptl_sample_conditions.label 1 298.0 atm 1.0 7.5 0.04 ? pH K ? 2 298.0 atm 1.0 7.5 0.04 ? pH K ? 3 298.0 atm 1.0 7.5 0.04 ? pH K ? 4 298.0 atm 1.0 7.5 0.04 ? pH K ? # loop_ _pdbx_nmr_sample_details.solution_id _pdbx_nmr_sample_details.contents _pdbx_nmr_sample_details.solvent_system _pdbx_nmr_sample_details.label _pdbx_nmr_sample_details.type _pdbx_nmr_sample_details.details 1 '90% H2O/10% D2O' ? ? ? ? 2 '100% D2O' ? ? ? ? # loop_ _pdbx_nmr_spectrometer.spectrometer_id _pdbx_nmr_spectrometer.model _pdbx_nmr_spectrometer.manufacturer _pdbx_nmr_spectrometer.field_strength _pdbx_nmr_spectrometer.type 1 INOVA Varian 750 ? 2 INOVA Varian 500 ? 3 INOVA Varian 600 ? 4 INOVA Varian 750 ? # _pdbx_nmr_refine.entry_id 2XKU _pdbx_nmr_refine.method NONE _pdbx_nmr_refine.details 'THE CCPN NMR ASSIGNMENT AND DATA ANALYSIS APPLICATION' _pdbx_nmr_refine.software_ordinal 1 # _pdbx_nmr_details.entry_id 2XKU _pdbx_nmr_details.text 'THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY ON 13C, 15N-LABELED BETA-2-MICROGLOBULIN.' # _pdbx_nmr_ensemble.entry_id 2XKU _pdbx_nmr_ensemble.conformers_calculated_total_number 30 _pdbx_nmr_ensemble.conformers_submitted_total_number 30 _pdbx_nmr_ensemble.conformer_selection_criteria 'LOWEST ENERGY' # loop_ _pdbx_nmr_software.classification _pdbx_nmr_software.name _pdbx_nmr_software.version _pdbx_nmr_software.authors _pdbx_nmr_software.ordinal refinement 'CcpNmr Analysis' 1.0 CCPN 1 'structure solution' 'CcpNmr Analysis' 2.1 ? 2 'structure solution' Xplor-NIH 2.17 ? 3 'structure solution' NMRPipe 2.5 ? 4 'structure solution' ARIA 2.1 ? 5 'structure solution' NMRView 5.22 ? 6 'structure solution' 'PASD ALGORITHM' 1.0 ? 7 'structure solution' VNMR 6.1C ? 8 # _exptl.entry_id 2XKU _exptl.method 'SOLUTION NMR' _exptl.crystals_number ? # _struct.entry_id 2XKU _struct.title 'Prion-like conversion during amyloid formation at atomic resolution' _struct.pdbx_model_details ? _struct.pdbx_CASP_flag ? _struct.pdbx_model_type_details ? # _struct_keywords.entry_id 2XKU _struct_keywords.pdbx_keywords 'IMMUNE SYSTEM' _struct_keywords.text 'AMYLOIDOSIS, IMMUNE SYSTEM, IG-DOMAIN' # _struct_asym.id A _struct_asym.pdbx_blank_PDB_chainid_flag N _struct_asym.pdbx_modified N _struct_asym.entity_id 1 _struct_asym.details ? # _struct_conf.conf_type_id HELX_P _struct_conf.id HELX_P1 _struct_conf.pdbx_PDB_helix_id 1 _struct_conf.beg_label_comp_id PRO _struct_conf.beg_label_asym_id A _struct_conf.beg_label_seq_id 27 _struct_conf.pdbx_beg_PDB_ins_code ? _struct_conf.end_label_comp_id ASP _struct_conf.end_label_asym_id A _struct_conf.end_label_seq_id 29 _struct_conf.pdbx_end_PDB_ins_code ? _struct_conf.beg_auth_comp_id PRO _struct_conf.beg_auth_asym_id A _struct_conf.beg_auth_seq_id 32 _struct_conf.end_auth_comp_id ASP _struct_conf.end_auth_asym_id A _struct_conf.end_auth_seq_id 34 _struct_conf.pdbx_PDB_helix_class 5 _struct_conf.details ? _struct_conf.pdbx_PDB_helix_length 3 # _struct_conf_type.id HELX_P _struct_conf_type.criteria ? _struct_conf_type.reference ? # _struct_conn.id disulf1 _struct_conn.conn_type_id disulf _struct_conn.pdbx_leaving_atom_flag ? _struct_conn.pdbx_PDB_id ? _struct_conn.ptnr1_label_asym_id A _struct_conn.ptnr1_label_comp_id CYS _struct_conn.ptnr1_label_seq_id 20 _struct_conn.ptnr1_label_atom_id SG _struct_conn.pdbx_ptnr1_label_alt_id ? _struct_conn.pdbx_ptnr1_PDB_ins_code ? _struct_conn.pdbx_ptnr1_standard_comp_id ? _struct_conn.ptnr1_symmetry 1_555 _struct_conn.ptnr2_label_asym_id A _struct_conn.ptnr2_label_comp_id CYS _struct_conn.ptnr2_label_seq_id 75 _struct_conn.ptnr2_label_atom_id SG _struct_conn.pdbx_ptnr2_label_alt_id ? _struct_conn.pdbx_ptnr2_PDB_ins_code ? _struct_conn.ptnr1_auth_asym_id A _struct_conn.ptnr1_auth_comp_id CYS _struct_conn.ptnr1_auth_seq_id 25 _struct_conn.ptnr2_auth_asym_id A _struct_conn.ptnr2_auth_comp_id CYS _struct_conn.ptnr2_auth_seq_id 80 _struct_conn.ptnr2_symmetry 1_555 _struct_conn.pdbx_ptnr3_label_atom_id ? _struct_conn.pdbx_ptnr3_label_seq_id ? _struct_conn.pdbx_ptnr3_label_comp_id ? _struct_conn.pdbx_ptnr3_label_asym_id ? _struct_conn.pdbx_ptnr3_label_alt_id ? _struct_conn.pdbx_ptnr3_PDB_ins_code ? _struct_conn.details ? _struct_conn.pdbx_dist_value 2.044 _struct_conn.pdbx_value_order ? _struct_conn.pdbx_role ? # _struct_conn_type.id disulf _struct_conn_type.criteria ? _struct_conn_type.reference ? # loop_ _struct_sheet.id _struct_sheet.type _struct_sheet.number_strands _struct_sheet.details AA ? 3 ? AB ? 4 ? # loop_ _struct_sheet_order.sheet_id _struct_sheet_order.range_id_1 _struct_sheet_order.range_id_2 _struct_sheet_order.offset _struct_sheet_order.sense AA 1 2 ? anti-parallel AA 2 3 ? anti-parallel AB 1 2 ? anti-parallel AB 2 3 ? anti-parallel AB 3 4 ? anti-parallel # loop_ _struct_sheet_range.sheet_id _struct_sheet_range.id _struct_sheet_range.beg_label_comp_id _struct_sheet_range.beg_label_asym_id _struct_sheet_range.beg_label_seq_id _struct_sheet_range.pdbx_beg_PDB_ins_code _struct_sheet_range.end_label_comp_id _struct_sheet_range.end_label_asym_id _struct_sheet_range.end_label_seq_id _struct_sheet_range.pdbx_end_PDB_ins_code _struct_sheet_range.beg_auth_comp_id _struct_sheet_range.beg_auth_asym_id _struct_sheet_range.beg_auth_seq_id _struct_sheet_range.end_auth_comp_id _struct_sheet_range.end_auth_asym_id _struct_sheet_range.end_auth_seq_id AA 1 GLN A 3 ? SER A 6 ? GLN A 8 SER A 11 AA 2 ASN A 16 ? VAL A 22 ? ASN A 21 VAL A 27 AA 3 LEU A 59 ? PHE A 65 ? LEU A 64 PHE A 70 AB 1 GLU A 39 ? ARG A 40 ? GLU A 44 ARG A 45 AB 2 ILE A 30 ? LYS A 36 ? ILE A 35 LYS A 41 AB 3 TYR A 73 ? HIS A 79 ? TYR A 78 HIS A 84 AB 4 LYS A 86 ? LYS A 89 ? LYS A 91 LYS A 94 # _database_PDB_matrix.entry_id 2XKU _database_PDB_matrix.origx[1][1] 1.000000 _database_PDB_matrix.origx[1][2] 0.000000 _database_PDB_matrix.origx[1][3] 0.000000 _database_PDB_matrix.origx[2][1] 0.000000 _database_PDB_matrix.origx[2][2] 1.000000 _database_PDB_matrix.origx[2][3] 0.000000 _database_PDB_matrix.origx[3][1] 0.000000 _database_PDB_matrix.origx[3][2] 0.000000 _database_PDB_matrix.origx[3][3] 1.000000 _database_PDB_matrix.origx_vector[1] 0.00000 _database_PDB_matrix.origx_vector[2] 0.00000 _database_PDB_matrix.origx_vector[3] 0.00000 # _atom_sites.entry_id 2XKU _atom_sites.fract_transf_matrix[1][1] 1.000000 _atom_sites.fract_transf_matrix[1][2] 0.000000 _atom_sites.fract_transf_matrix[1][3] 0.000000 _atom_sites.fract_transf_matrix[2][1] 0.000000 _atom_sites.fract_transf_matrix[2][2] 1.000000 _atom_sites.fract_transf_matrix[2][3] 0.000000 _atom_sites.fract_transf_matrix[3][1] 0.000000 _atom_sites.fract_transf_matrix[3][2] 0.000000 _atom_sites.fract_transf_matrix[3][3] 1.000000 _atom_sites.fract_transf_vector[1] 0.00000 _atom_sites.fract_transf_vector[2] 0.00000 _atom_sites.fract_transf_vector[3] 0.00000 # loop_ _atom_type.symbol C H N O S # loop_ _pdbx_poly_seq_scheme.asym_id _pdbx_poly_seq_scheme.entity_id _pdbx_poly_seq_scheme.seq_id _pdbx_poly_seq_scheme.mon_id _pdbx_poly_seq_scheme.ndb_seq_num _pdbx_poly_seq_scheme.pdb_seq_num _pdbx_poly_seq_scheme.auth_seq_num _pdbx_poly_seq_scheme.pdb_mon_id _pdbx_poly_seq_scheme.auth_mon_id _pdbx_poly_seq_scheme.pdb_strand_id _pdbx_poly_seq_scheme.pdb_ins_code _pdbx_poly_seq_scheme.hetero A 1 1 MET 1 6 6 MET MET A . n A 1 2 ILE 2 7 7 ILE ILE A . n A 1 3 GLN 3 8 8 GLN GLN A . n A 1 4 VAL 4 9 9 VAL VAL A . n A 1 5 TYR 5 10 10 TYR TYR A . n A 1 6 SER 6 11 11 SER SER A . n A 1 7 ARG 7 12 12 ARG ARG A . n A 1 8 HIS 8 13 13 HIS HIS A . n A 1 9 PRO 9 14 14 PRO PRO A . n A 1 10 ALA 10 15 15 ALA ALA A . n A 1 11 GLU 11 16 16 GLU GLU A . n A 1 12 ASN 12 17 17 ASN ASN A . n A 1 13 GLY 13 18 18 GLY GLY A . n A 1 14 LYS 14 19 19 LYS LYS A . n A 1 15 SER 15 20 20 SER SER A . n A 1 16 ASN 16 21 21 ASN ASN A . n A 1 17 PHE 17 22 22 PHE PHE A . n A 1 18 LEU 18 23 23 LEU LEU A . n A 1 19 ASN 19 24 24 ASN ASN A . n A 1 20 CYS 20 25 25 CYS CYS A . n A 1 21 TYR 21 26 26 TYR TYR A . n A 1 22 VAL 22 27 27 VAL VAL A . n A 1 23 SER 23 28 28 SER SER A . n A 1 24 GLY 24 29 29 GLY GLY A . n A 1 25 PHE 25 30 30 PHE PHE A . n A 1 26 HIS 26 31 31 HIS HIS A . n A 1 27 PRO 27 32 32 PRO PRO A . n A 1 28 SER 28 33 33 SER SER A . n A 1 29 ASP 29 34 34 ASP ASP A . n A 1 30 ILE 30 35 35 ILE ILE A . n A 1 31 GLU 31 36 36 GLU GLU A . n A 1 32 VAL 32 37 37 VAL VAL A . n A 1 33 ASP 33 38 38 ASP ASP A . n A 1 34 LEU 34 39 39 LEU LEU A . n A 1 35 LEU 35 40 40 LEU LEU A . n A 1 36 LYS 36 41 41 LYS LYS A . n A 1 37 ASN 37 42 42 ASN ASN A . n A 1 38 GLY 38 43 43 GLY GLY A . n A 1 39 GLU 39 44 44 GLU GLU A . n A 1 40 ARG 40 45 45 ARG ARG A . n A 1 41 ILE 41 46 46 ILE ILE A . n A 1 42 GLU 42 47 47 GLU GLU A . n A 1 43 LYS 43 48 48 LYS LYS A . n A 1 44 VAL 44 49 49 VAL VAL A . n A 1 45 GLU 45 50 50 GLU GLU A . n A 1 46 HIS 46 51 51 HIS HIS A . n A 1 47 SER 47 52 52 SER SER A . n A 1 48 ASP 48 53 53 ASP ASP A . n A 1 49 LEU 49 54 54 LEU LEU A . n A 1 50 SER 50 55 55 SER SER A . n A 1 51 PHE 51 56 56 PHE PHE A . n A 1 52 SER 52 57 57 SER SER A . n A 1 53 LYS 53 58 58 LYS LYS A . n A 1 54 ASP 54 59 59 ASP ASP A . n A 1 55 TRP 55 60 60 TRP TRP A . n A 1 56 SER 56 61 61 SER SER A . n A 1 57 PHE 57 62 62 PHE PHE A . n A 1 58 TYR 58 63 63 TYR TYR A . n A 1 59 LEU 59 64 64 LEU LEU A . n A 1 60 LEU 60 65 65 LEU LEU A . n A 1 61 TYR 61 66 66 TYR TYR A . n A 1 62 TYR 62 67 67 TYR TYR A . n A 1 63 THR 63 68 68 THR THR A . n A 1 64 GLU 64 69 69 GLU GLU A . n A 1 65 PHE 65 70 70 PHE PHE A . n A 1 66 THR 66 71 71 THR THR A . n A 1 67 PRO 67 72 72 PRO PRO A . n A 1 68 THR 68 73 73 THR THR A . n A 1 69 GLU 69 74 74 GLU GLU A . n A 1 70 LYS 70 75 75 LYS LYS A . n A 1 71 ASP 71 76 76 ASP ASP A . n A 1 72 GLU 72 77 77 GLU GLU A . n A 1 73 TYR 73 78 78 TYR TYR A . n A 1 74 ALA 74 79 79 ALA ALA A . n A 1 75 CYS 75 80 80 CYS CYS A . n A 1 76 ARG 76 81 81 ARG ARG A . n A 1 77 VAL 77 82 82 VAL VAL A . n A 1 78 ASN 78 83 83 ASN ASN A . n A 1 79 HIS 79 84 84 HIS HIS A . n A 1 80 VAL 80 85 85 VAL VAL A . n A 1 81 THR 81 86 86 THR THR A . n A 1 82 LEU 82 87 87 LEU LEU A . n A 1 83 SER 83 88 88 SER SER A . n A 1 84 GLN 84 89 89 GLN GLN A . n A 1 85 PRO 85 90 90 PRO PRO A . n A 1 86 LYS 86 91 91 LYS LYS A . n A 1 87 ILE 87 92 92 ILE ILE A . n A 1 88 VAL 88 93 93 VAL VAL A . n A 1 89 LYS 89 94 94 LYS LYS A . n A 1 90 TRP 90 95 95 TRP TRP A . n A 1 91 ASP 91 96 96 ASP ASP A . n A 1 92 ARG 92 97 97 ARG ARG A . n A 1 93 ASP 93 98 98 ASP ASP A . n A 1 94 MET 94 99 99 MET MET A . n # _pdbx_struct_assembly.id 1 _pdbx_struct_assembly.details author_defined_assembly _pdbx_struct_assembly.method_details ? _pdbx_struct_assembly.oligomeric_details monomeric _pdbx_struct_assembly.oligomeric_count 1 # _pdbx_struct_assembly_gen.assembly_id 1 _pdbx_struct_assembly_gen.oper_expression 1 _pdbx_struct_assembly_gen.asym_id_list A # _pdbx_struct_oper_list.id 1 _pdbx_struct_oper_list.type 'identity operation' _pdbx_struct_oper_list.name 1_555 _pdbx_struct_oper_list.symmetry_operation x,y,z _pdbx_struct_oper_list.matrix[1][1] 1.0000000000 _pdbx_struct_oper_list.matrix[1][2] 0.0000000000 _pdbx_struct_oper_list.matrix[1][3] 0.0000000000 _pdbx_struct_oper_list.vector[1] 0.0000000000 _pdbx_struct_oper_list.matrix[2][1] 0.0000000000 _pdbx_struct_oper_list.matrix[2][2] 1.0000000000 _pdbx_struct_oper_list.matrix[2][3] 0.0000000000 _pdbx_struct_oper_list.vector[2] 0.0000000000 _pdbx_struct_oper_list.matrix[3][1] 0.0000000000 _pdbx_struct_oper_list.matrix[3][2] 0.0000000000 _pdbx_struct_oper_list.matrix[3][3] 1.0000000000 _pdbx_struct_oper_list.vector[3] 0.0000000000 # loop_ _pdbx_audit_revision_history.ordinal _pdbx_audit_revision_history.data_content_type _pdbx_audit_revision_history.major_revision _pdbx_audit_revision_history.minor_revision _pdbx_audit_revision_history.revision_date 1 'Structure model' 1 0 2011-02-09 2 'Structure model' 1 1 2011-05-08 3 'Structure model' 1 2 2011-07-13 4 'Structure model' 1 3 2018-01-17 5 'Structure model' 1 4 2020-01-15 6 'Structure model' 1 5 2023-06-14 # _pdbx_audit_revision_details.ordinal 1 _pdbx_audit_revision_details.revision_ordinal 1 _pdbx_audit_revision_details.data_content_type 'Structure model' _pdbx_audit_revision_details.provider repository _pdbx_audit_revision_details.type 'Initial release' _pdbx_audit_revision_details.description ? _pdbx_audit_revision_details.details ? # loop_ _pdbx_audit_revision_group.ordinal _pdbx_audit_revision_group.revision_ordinal _pdbx_audit_revision_group.data_content_type _pdbx_audit_revision_group.group 1 2 'Structure model' 'Version format compliance' 2 3 'Structure model' 'Version format compliance' 3 4 'Structure model' 'Data collection' 4 4 'Structure model' 'Database references' 5 5 'Structure model' 'Data collection' 6 5 'Structure model' Other 7 6 'Structure model' 'Database references' 8 6 'Structure model' Other # loop_ _pdbx_audit_revision_category.ordinal _pdbx_audit_revision_category.revision_ordinal _pdbx_audit_revision_category.data_content_type _pdbx_audit_revision_category.category 1 4 'Structure model' citation 2 4 'Structure model' pdbx_nmr_spectrometer 3 5 'Structure model' pdbx_database_status 4 5 'Structure model' pdbx_nmr_software 5 6 'Structure model' database_2 6 6 'Structure model' pdbx_database_status # loop_ _pdbx_audit_revision_item.ordinal _pdbx_audit_revision_item.revision_ordinal _pdbx_audit_revision_item.data_content_type _pdbx_audit_revision_item.item 1 4 'Structure model' '_citation.page_last' 2 4 'Structure model' '_pdbx_nmr_spectrometer.field_strength' 3 4 'Structure model' '_pdbx_nmr_spectrometer.manufacturer' 4 4 'Structure model' '_pdbx_nmr_spectrometer.model' 5 5 'Structure model' '_pdbx_database_status.status_code_cs' 6 5 'Structure model' '_pdbx_database_status.status_code_mr' 7 5 'Structure model' '_pdbx_nmr_software.name' 8 6 'Structure model' '_database_2.pdbx_DOI' 9 6 'Structure model' '_database_2.pdbx_database_accession' 10 6 'Structure model' '_pdbx_database_status.status_code_nmr_data' # loop_ _pdbx_database_remark.id _pdbx_database_remark.text 650 ; HELIX DETERMINATION METHOD: AUTHOR PROVIDED. ; 700 ; SHEET DETERMINATION METHOD: AUTHOR PROVIDED. ; # _pdbx_entry_details.entry_id 2XKU _pdbx_entry_details.compound_details ? _pdbx_entry_details.source_details ? _pdbx_entry_details.nonpolymer_details ? _pdbx_entry_details.sequence_details 'DELTA-N-6, 5-MET' _pdbx_entry_details.has_ligand_of_interest ? # loop_ _pdbx_validate_close_contact.id _pdbx_validate_close_contact.PDB_model_num _pdbx_validate_close_contact.auth_atom_id_1 _pdbx_validate_close_contact.auth_asym_id_1 _pdbx_validate_close_contact.auth_comp_id_1 _pdbx_validate_close_contact.auth_seq_id_1 _pdbx_validate_close_contact.PDB_ins_code_1 _pdbx_validate_close_contact.label_alt_id_1 _pdbx_validate_close_contact.auth_atom_id_2 _pdbx_validate_close_contact.auth_asym_id_2 _pdbx_validate_close_contact.auth_comp_id_2 _pdbx_validate_close_contact.auth_seq_id_2 _pdbx_validate_close_contact.PDB_ins_code_2 _pdbx_validate_close_contact.label_alt_id_2 _pdbx_validate_close_contact.dist 1 2 HG A SER 20 ? ? HG3 A GLU 69 ? ? 1.21 2 2 HG22 A VAL 49 ? ? HB A THR 68 ? ? 1.29 3 2 HD3 A ARG 97 ? ? HB2 A ASP 98 ? ? 1.29 4 2 HZ3 A LYS 41 ? ? OD2 A ASP 76 ? ? 1.54 5 3 HB2 A SER 33 ? ? HA A PHE 56 ? ? 1.18 6 4 HG21 A VAL 49 ? ? HB A THR 68 ? ? 1.22 7 4 O A LEU 87 ? ? HG A SER 88 ? ? 1.55 8 6 HE1 A TRP 60 ? ? HA A TYR 63 ? ? 1.30 9 7 HA2 A GLY 29 ? ? HH2 A TRP 60 ? ? 1.18 10 7 HG21 A VAL 49 ? ? HB A THR 68 ? ? 1.31 11 8 HG21 A VAL 49 ? ? HB A THR 68 ? ? 1.27 12 9 HB2 A HIS 13 ? ? HD22 A ASN 21 ? ? 1.23 13 9 HG21 A VAL 49 ? ? HB A THR 68 ? ? 1.27 14 10 HG22 A VAL 49 ? ? HB A THR 68 ? ? 1.27 15 13 HG2 A PRO 32 ? ? HD21 A LEU 54 ? ? 1.17 16 13 HG21 A VAL 49 ? ? HB A THR 68 ? ? 1.31 17 13 O A THR 73 ? ? HH22 A ARG 97 ? ? 1.56 18 14 HG22 A VAL 49 ? ? HB A THR 68 ? ? 1.19 19 14 HG1 A THR 73 ? ? OD1 A ASP 76 ? ? 1.58 20 15 HG22 A VAL 49 ? ? HB A THR 68 ? ? 1.20 21 16 HB2 A ALA 15 ? ? HH2 A TRP 95 ? ? 1.29 22 17 HG21 A VAL 49 ? ? HB A THR 68 ? ? 1.30 23 18 HG22 A VAL 49 ? ? HB A THR 68 ? ? 1.25 24 19 HD2 A HIS 31 ? ? HB2 A ASP 34 ? ? 1.22 25 19 HB2 A ALA 15 ? ? HH2 A TRP 95 ? ? 1.32 26 20 HG22 A VAL 49 ? ? HB A THR 68 ? ? 1.31 27 20 HB2 A ALA 15 ? ? HH2 A TRP 95 ? ? 1.34 28 20 HZ1 A LYS 58 ? ? OD2 A ASP 59 ? ? 1.59 29 21 HG21 A VAL 49 ? ? HB A THR 68 ? ? 1.26 30 21 HB2 A SER 33 ? ? HA A SER 55 ? ? 1.26 31 21 HB2 A HIS 13 ? ? HD21 A ASN 21 ? ? 1.31 32 21 HB2 A ALA 15 ? ? HH2 A TRP 95 ? ? 1.35 33 21 HE1 A TRP 60 ? ? HD2 A TYR 63 ? ? 1.35 34 22 HG21 A VAL 49 ? ? HB A THR 68 ? ? 1.30 35 24 HG2 A GLU 74 ? ? HZ1 A LYS 75 ? ? 1.21 36 25 HB2 A PRO 32 ? ? HD21 A LEU 54 ? ? 1.13 37 25 HG22 A VAL 49 ? ? HB A THR 68 ? ? 1.28 38 26 HG22 A VAL 49 ? ? HB A THR 68 ? ? 1.17 39 26 OD2 A ASP 53 ? ? HG A SER 55 ? ? 1.58 40 27 HG22 A VAL 49 ? ? HB A THR 68 ? ? 1.34 41 27 O A ASP 76 ? ? HH21 A ARG 97 ? ? 1.59 42 27 O A THR 73 ? ? HH22 A ARG 97 ? ? 1.60 43 28 HG21 A VAL 49 ? ? HB A THR 68 ? ? 1.33 44 29 HG2 A PRO 32 ? ? HD12 A LEU 54 ? ? 1.29 45 30 HG21 A VAL 49 ? ? HB A THR 68 ? ? 1.34 # loop_ _pdbx_validate_torsion.id _pdbx_validate_torsion.PDB_model_num _pdbx_validate_torsion.auth_comp_id _pdbx_validate_torsion.auth_asym_id _pdbx_validate_torsion.auth_seq_id _pdbx_validate_torsion.PDB_ins_code _pdbx_validate_torsion.label_alt_id _pdbx_validate_torsion.phi _pdbx_validate_torsion.psi 1 1 ASN A 17 ? ? -50.97 101.41 2 1 ASN A 21 ? ? -170.30 -176.94 3 1 HIS A 31 ? ? -38.87 115.47 4 1 ASN A 42 ? ? 39.25 50.60 5 1 GLU A 47 ? ? 116.68 -31.69 6 1 PHE A 56 ? ? 67.61 -55.35 7 1 SER A 57 ? ? -147.49 -84.14 8 1 ASP A 59 ? ? 74.80 179.81 9 1 TYR A 63 ? ? 150.98 92.27 10 1 ASP A 96 ? ? -64.71 99.29 11 1 ARG A 97 ? ? -176.05 -9.68 12 1 ASP A 98 ? ? -164.99 0.27 13 2 ASN A 21 ? ? -148.35 -143.39 14 2 ASN A 42 ? ? 39.26 50.38 15 2 ILE A 46 ? ? -66.47 -80.76 16 2 GLU A 47 ? ? 135.01 -33.39 17 2 PHE A 56 ? ? 74.60 -25.18 18 2 SER A 57 ? ? -137.62 -54.60 19 2 PHE A 62 ? ? -143.49 14.67 20 2 TYR A 63 ? ? 138.50 97.47 21 2 ARG A 97 ? ? -178.21 -11.42 22 2 ASP A 98 ? ? -160.34 -4.95 23 3 ASN A 21 ? ? -150.47 -157.32 24 3 ASN A 42 ? ? 39.11 48.58 25 3 ILE A 46 ? ? -66.19 -74.29 26 3 GLU A 47 ? ? 137.29 -38.35 27 3 LEU A 54 ? ? -106.32 -158.68 28 3 PHE A 56 ? ? -155.01 -61.81 29 3 SER A 57 ? ? -160.87 56.51 30 3 SER A 61 ? ? -138.66 -34.84 31 3 SER A 88 ? ? 77.91 -30.83 32 3 ARG A 97 ? ? -169.44 -12.74 33 3 ASP A 98 ? ? -166.34 -1.92 34 4 ALA A 15 ? ? -57.54 105.71 35 4 SER A 28 ? ? -69.68 -170.17 36 4 PHE A 30 ? ? 73.96 147.19 37 4 ASN A 42 ? ? 39.91 49.68 38 4 GLU A 47 ? ? 115.40 -28.27 39 4 LEU A 54 ? ? 58.35 155.90 40 4 LYS A 58 ? ? -146.08 -34.53 41 4 TRP A 60 ? ? -171.16 -169.69 42 4 SER A 61 ? ? -176.90 59.49 43 4 PHE A 62 ? ? -100.84 -155.56 44 4 SER A 88 ? ? 64.79 -24.35 45 4 ASP A 96 ? ? -65.44 97.91 46 4 ARG A 97 ? ? -178.00 -10.96 47 4 ASP A 98 ? ? -167.75 -5.17 48 5 ASN A 17 ? ? -39.47 98.70 49 5 PRO A 32 ? ? -57.40 -0.14 50 5 ASN A 42 ? ? 39.36 50.55 51 5 ILE A 46 ? ? -59.24 -74.11 52 5 GLU A 47 ? ? 136.44 -39.62 53 5 LEU A 54 ? ? 168.95 147.02 54 5 SER A 57 ? ? -164.38 -73.02 55 5 LYS A 58 ? ? 59.57 77.22 56 5 ASP A 59 ? ? -171.83 -62.69 57 5 PHE A 62 ? ? 46.72 -79.21 58 5 SER A 88 ? ? 73.38 -29.88 59 5 ASP A 96 ? ? -66.77 99.87 60 5 ARG A 97 ? ? -164.89 -11.92 61 5 ASP A 98 ? ? -177.48 -0.61 62 6 ASN A 17 ? ? -36.24 113.70 63 6 ASN A 21 ? ? -159.28 -154.14 64 6 SER A 28 ? ? -72.65 -169.28 65 6 PHE A 30 ? ? 45.11 -163.91 66 6 PRO A 32 ? ? -39.03 -35.40 67 6 GLU A 47 ? ? 119.03 -27.54 68 6 LEU A 54 ? ? 64.27 129.90 69 6 SER A 57 ? ? 67.91 149.52 70 6 LYS A 58 ? ? -168.08 113.09 71 6 ASP A 59 ? ? 53.82 -163.75 72 6 TYR A 63 ? ? 52.44 166.17 73 6 GLU A 74 ? ? -65.66 2.51 74 6 SER A 88 ? ? 72.08 -27.40 75 6 ARG A 97 ? ? -179.34 -18.25 76 6 ASP A 98 ? ? -158.49 -7.56 77 7 ASN A 21 ? ? -148.91 -155.70 78 7 SER A 28 ? ? -72.56 -165.82 79 7 PRO A 32 ? ? -45.52 -16.65 80 7 ASN A 42 ? ? 39.92 50.99 81 7 ILE A 46 ? ? -81.68 -70.99 82 7 GLU A 47 ? ? 128.11 -38.66 83 7 LEU A 54 ? ? 83.38 154.62 84 7 ASP A 59 ? ? -144.96 -46.15 85 7 TRP A 60 ? ? -51.04 109.80 86 7 PHE A 62 ? ? -64.91 -80.92 87 7 SER A 88 ? ? 74.56 -25.56 88 7 ARG A 97 ? ? 169.94 -16.71 89 8 ASN A 21 ? ? -156.01 -150.91 90 8 SER A 28 ? ? -73.91 -165.70 91 8 PHE A 30 ? ? -19.30 137.08 92 8 ASN A 42 ? ? 38.29 50.37 93 8 GLU A 47 ? ? 123.79 -32.44 94 8 LYS A 58 ? ? 70.55 153.68 95 8 TYR A 63 ? ? 93.43 111.43 96 8 GLU A 74 ? ? -59.27 -6.66 97 8 ARG A 97 ? ? -174.36 -8.90 98 8 ASP A 98 ? ? -164.04 -2.99 99 9 SER A 28 ? ? -73.32 -166.04 100 9 PHE A 30 ? ? 78.64 177.75 101 9 PRO A 32 ? ? -39.48 -37.30 102 9 ASN A 42 ? ? 36.90 50.90 103 9 GLU A 47 ? ? 128.47 -43.23 104 9 LEU A 54 ? ? -100.23 -164.12 105 9 LYS A 58 ? ? -69.97 -79.89 106 9 PHE A 62 ? ? 49.76 -75.26 107 9 SER A 88 ? ? 74.33 -22.95 108 9 ASP A 96 ? ? -67.04 95.81 109 9 ARG A 97 ? ? 179.74 -13.26 110 9 ASP A 98 ? ? -154.46 -6.64 111 10 ALA A 15 ? ? -59.01 103.11 112 10 ASN A 17 ? ? -40.64 109.32 113 10 ILE A 46 ? ? -59.14 -71.24 114 10 GLU A 47 ? ? 135.16 -37.48 115 10 LEU A 54 ? ? 42.65 174.33 116 10 TRP A 60 ? ? -162.67 88.88 117 10 PHE A 62 ? ? 46.64 -90.45 118 10 SER A 88 ? ? 81.24 -25.59 119 10 ARG A 97 ? ? 175.10 -15.47 120 10 ASP A 98 ? ? -145.63 -21.73 121 11 ALA A 15 ? ? -51.06 109.03 122 11 ASN A 21 ? ? -153.30 -151.17 123 11 PRO A 32 ? ? -64.68 8.77 124 11 ASN A 42 ? ? 37.99 47.48 125 11 GLU A 47 ? ? 118.97 -31.37 126 11 ASP A 59 ? ? -168.20 -43.83 127 11 ASP A 96 ? ? -62.72 97.78 128 11 ARG A 97 ? ? -167.19 -12.88 129 11 ASP A 98 ? ? -159.56 -6.47 130 12 ASN A 17 ? ? -33.08 111.52 131 12 ASN A 21 ? ? -149.53 -152.89 132 12 PRO A 32 ? ? -55.92 0.06 133 12 ILE A 46 ? ? -65.71 -75.65 134 12 GLU A 47 ? ? 136.41 -38.11 135 12 LEU A 54 ? ? 62.73 99.21 136 12 PHE A 56 ? ? -153.67 29.76 137 12 LYS A 58 ? ? 41.44 -157.25 138 12 ASP A 59 ? ? 61.04 -143.24 139 12 PHE A 62 ? ? -113.33 -73.25 140 12 GLN A 89 ? ? -163.12 119.53 141 12 ARG A 97 ? ? -179.03 -11.51 142 12 ASP A 98 ? ? -167.37 -3.73 143 13 ALA A 15 ? ? -53.08 101.54 144 13 ASN A 17 ? ? -65.65 98.15 145 13 ASN A 21 ? ? -155.22 -154.56 146 13 ASN A 42 ? ? 35.60 54.39 147 13 GLU A 47 ? ? 116.88 -28.81 148 13 LEU A 54 ? ? 61.78 114.53 149 13 PHE A 62 ? ? -125.16 -82.66 150 13 GLU A 74 ? ? -56.42 -7.29 151 13 ARG A 97 ? ? -174.12 -10.93 152 13 ASP A 98 ? ? -158.92 -7.05 153 14 ALA A 15 ? ? -60.35 99.45 154 14 ASN A 17 ? ? -36.90 98.99 155 14 ASN A 42 ? ? 37.63 52.19 156 14 GLU A 47 ? ? 127.43 -36.45 157 14 LEU A 54 ? ? -102.33 47.54 158 14 LYS A 58 ? ? -112.63 73.95 159 14 SER A 61 ? ? -152.74 85.82 160 14 PHE A 62 ? ? -122.60 -77.66 161 14 LEU A 64 ? ? 179.85 141.38 162 14 LEU A 65 ? ? 179.62 119.42 163 14 SER A 88 ? ? 79.67 -31.25 164 14 ASP A 96 ? ? -62.13 99.58 165 14 ARG A 97 ? ? -173.62 -10.11 166 14 ASP A 98 ? ? -156.77 -5.82 167 15 ASN A 21 ? ? -153.30 -154.14 168 15 ASN A 42 ? ? 38.22 51.74 169 15 ILE A 46 ? ? -67.48 -78.41 170 15 GLU A 47 ? ? 129.54 -31.97 171 15 LYS A 48 ? ? -80.88 48.84 172 15 LEU A 54 ? ? 170.55 151.00 173 15 TYR A 63 ? ? 71.41 148.31 174 15 SER A 88 ? ? 76.19 -26.09 175 15 ARG A 97 ? ? -172.65 -11.98 176 15 ASP A 98 ? ? -170.63 3.84 177 16 ASN A 21 ? ? -152.88 -153.84 178 16 SER A 28 ? ? -72.57 -165.78 179 16 ILE A 46 ? ? -64.42 -77.77 180 16 GLU A 47 ? ? 141.24 -40.93 181 16 LYS A 48 ? ? -80.65 48.28 182 16 ASP A 59 ? ? -144.33 59.33 183 16 SER A 61 ? ? -143.16 -44.08 184 16 TYR A 63 ? ? -18.72 152.86 185 16 ASP A 96 ? ? -55.88 99.39 186 16 ARG A 97 ? ? -179.80 -13.00 187 16 ASP A 98 ? ? -158.91 -16.00 188 17 ALA A 15 ? ? -59.19 100.58 189 17 GLU A 47 ? ? 123.42 -36.16 190 17 LEU A 54 ? ? 60.60 118.70 191 17 PHE A 56 ? ? -152.95 73.64 192 17 ASP A 59 ? ? 154.46 -53.62 193 17 PHE A 62 ? ? 44.51 -86.49 194 17 GLU A 74 ? ? -58.57 -6.51 195 17 SER A 88 ? ? 79.07 -21.49 196 17 ASP A 96 ? ? -66.30 97.85 197 17 ARG A 97 ? ? -173.74 -14.30 198 17 ASP A 98 ? ? -161.26 -4.64 199 18 ASN A 21 ? ? -150.75 -154.11 200 18 PRO A 32 ? ? -39.81 -36.28 201 18 ASN A 42 ? ? 36.30 54.59 202 18 GLU A 47 ? ? 123.28 -34.75 203 18 LEU A 54 ? ? 77.25 -19.11 204 18 SER A 57 ? ? -148.70 -63.88 205 18 ARG A 97 ? ? 169.95 -14.66 206 18 ASP A 98 ? ? -144.57 -20.84 207 19 ASN A 42 ? ? 39.41 50.62 208 19 ILE A 46 ? ? -63.42 -78.47 209 19 GLU A 47 ? ? 132.37 -33.84 210 19 TRP A 60 ? ? -166.29 114.29 211 19 PHE A 62 ? ? -109.01 -64.35 212 19 GLU A 74 ? ? -68.04 5.63 213 19 SER A 88 ? ? 72.83 -28.97 214 19 ARG A 97 ? ? 177.00 -9.66 215 19 ASP A 98 ? ? -156.72 -7.48 216 20 ASN A 17 ? ? -51.72 97.53 217 20 ASN A 21 ? ? -152.00 -139.79 218 20 ASN A 42 ? ? 39.75 51.18 219 20 GLU A 47 ? ? 120.21 -33.51 220 20 LYS A 48 ? ? -81.16 46.59 221 20 PHE A 62 ? ? -51.25 -99.58 222 20 TYR A 63 ? ? 179.04 166.05 223 20 GLU A 74 ? ? -69.47 4.73 224 20 SER A 88 ? ? 73.69 -30.64 225 20 ASP A 96 ? ? -65.97 97.38 226 20 ARG A 97 ? ? -171.97 -10.44 227 20 ASP A 98 ? ? -168.93 -3.19 228 21 ASN A 17 ? ? -21.17 98.06 229 21 ASN A 21 ? ? -145.08 -124.25 230 21 GLU A 47 ? ? 118.41 -32.22 231 21 PHE A 56 ? ? -103.53 44.14 232 21 ASP A 59 ? ? 61.28 -156.40 233 21 TYR A 63 ? ? 71.82 148.67 234 21 SER A 88 ? ? 77.40 -30.62 235 21 ARG A 97 ? ? 166.71 -16.45 236 22 ALA A 15 ? ? -58.03 102.22 237 22 PRO A 32 ? ? -39.14 -39.86 238 22 ASN A 42 ? ? 38.80 51.14 239 22 ILE A 46 ? ? -61.74 -71.53 240 22 GLU A 47 ? ? 129.04 -36.11 241 22 LEU A 54 ? ? 50.46 162.71 242 22 SER A 57 ? ? -49.83 -81.49 243 22 LYS A 58 ? ? 61.33 166.48 244 22 TRP A 60 ? ? 178.92 -150.46 245 22 SER A 61 ? ? -63.42 69.66 246 22 SER A 88 ? ? 73.71 -28.72 247 22 ASP A 96 ? ? -68.35 97.25 248 22 ARG A 97 ? ? 176.35 -16.60 249 23 ASN A 17 ? ? -66.48 97.33 250 23 ASN A 42 ? ? 38.85 54.31 251 23 GLU A 47 ? ? 111.77 -27.09 252 23 LYS A 48 ? ? -82.68 47.10 253 23 SER A 57 ? ? 64.53 -159.34 254 23 LYS A 58 ? ? 68.78 159.59 255 23 TRP A 60 ? ? -156.14 4.42 256 23 PHE A 62 ? ? -101.25 -66.81 257 23 SER A 88 ? ? 75.41 -26.03 258 23 ASP A 96 ? ? -64.92 95.48 259 23 ARG A 97 ? ? -170.92 -11.77 260 23 ASP A 98 ? ? -168.46 -5.72 261 24 ALA A 15 ? ? -57.52 106.96 262 24 ASN A 21 ? ? -150.71 -150.28 263 24 SER A 28 ? ? -72.73 -164.90 264 24 GLU A 47 ? ? 121.96 -27.61 265 24 LYS A 48 ? ? -84.09 47.47 266 24 LEU A 54 ? ? -41.08 -120.90 267 24 ASP A 59 ? ? -143.08 -60.27 268 24 TRP A 60 ? ? 166.88 153.51 269 24 PHE A 62 ? ? 26.12 47.45 270 24 TYR A 63 ? ? 90.09 109.16 271 24 GLU A 74 ? ? -68.64 1.31 272 24 ARG A 97 ? ? 165.19 -21.52 273 25 ASN A 21 ? ? -151.22 -159.27 274 25 ILE A 46 ? ? -69.28 -76.88 275 25 GLU A 47 ? ? 137.03 -45.89 276 25 LEU A 54 ? ? 76.05 126.18 277 25 SER A 61 ? ? -38.69 122.06 278 25 PHE A 62 ? ? -104.95 -66.72 279 25 GLU A 74 ? ? -58.91 -6.13 280 25 ARG A 97 ? ? 178.82 -9.98 281 25 ASP A 98 ? ? -156.09 -11.68 282 26 ASN A 17 ? ? -40.93 99.58 283 26 ASN A 21 ? ? -150.60 -155.82 284 26 SER A 57 ? ? 73.84 -59.46 285 26 LYS A 58 ? ? -92.30 -152.64 286 26 SER A 61 ? ? -61.50 95.22 287 26 TYR A 63 ? ? 154.33 85.48 288 26 ARG A 97 ? ? -164.60 -11.52 289 26 ASP A 98 ? ? -171.52 -1.00 290 27 ASN A 17 ? ? -38.70 113.30 291 27 ASN A 42 ? ? 38.04 51.79 292 27 GLU A 47 ? ? 115.18 -25.53 293 27 LEU A 54 ? ? 75.63 -22.02 294 27 SER A 57 ? ? -146.48 -72.58 295 27 TYR A 63 ? ? 152.76 82.41 296 27 ASP A 96 ? ? -66.44 99.00 297 27 ARG A 97 ? ? -174.40 -11.31 298 27 ASP A 98 ? ? -164.05 -3.09 299 28 ALA A 15 ? ? -53.54 104.65 300 28 ASN A 21 ? ? -153.54 -147.59 301 28 PRO A 32 ? ? -54.73 -9.31 302 28 GLU A 47 ? ? 119.74 -35.12 303 28 TRP A 60 ? ? -152.97 73.97 304 28 SER A 61 ? ? -100.51 63.64 305 28 PHE A 62 ? ? -157.92 -109.90 306 28 ARG A 97 ? ? -178.65 -9.50 307 28 ASP A 98 ? ? -166.48 -1.29 308 29 ASN A 17 ? ? -44.33 107.41 309 29 ASN A 21 ? ? -153.60 -159.90 310 29 SER A 28 ? ? -73.61 -165.70 311 29 PRO A 32 ? ? -55.77 -7.47 312 29 ILE A 46 ? ? -59.69 -70.94 313 29 GLU A 47 ? ? 128.01 -34.87 314 29 LEU A 54 ? ? 56.36 135.88 315 29 LYS A 58 ? ? -132.10 -138.27 316 29 ASP A 59 ? ? -75.74 30.97 317 29 PHE A 62 ? ? -109.21 -142.12 318 29 GLU A 74 ? ? -69.98 2.75 319 29 ARG A 97 ? ? -177.96 -15.52 320 29 ASP A 98 ? ? -155.47 -6.71 321 30 ASN A 17 ? ? -38.92 100.58 322 30 ASN A 21 ? ? -152.11 -159.75 323 30 SER A 28 ? ? -74.82 -163.81 324 30 PHE A 30 ? ? -33.43 126.93 325 30 GLU A 47 ? ? 123.18 -32.63 326 30 PHE A 56 ? ? 56.67 -66.73 327 30 LYS A 58 ? ? 61.53 -91.49 328 30 ASP A 59 ? ? 63.92 -77.57 329 30 PHE A 62 ? ? -106.82 -149.74 330 30 ARG A 97 ? ? -178.69 -16.29 331 30 ASP A 98 ? ? -164.48 -5.50 # loop_ _pdbx_validate_peptide_omega.id _pdbx_validate_peptide_omega.PDB_model_num _pdbx_validate_peptide_omega.auth_comp_id_1 _pdbx_validate_peptide_omega.auth_asym_id_1 _pdbx_validate_peptide_omega.auth_seq_id_1 _pdbx_validate_peptide_omega.PDB_ins_code_1 _pdbx_validate_peptide_omega.label_alt_id_1 _pdbx_validate_peptide_omega.auth_comp_id_2 _pdbx_validate_peptide_omega.auth_asym_id_2 _pdbx_validate_peptide_omega.auth_seq_id_2 _pdbx_validate_peptide_omega.PDB_ins_code_2 _pdbx_validate_peptide_omega.label_alt_id_2 _pdbx_validate_peptide_omega.omega 1 9 SER A 28 ? ? GLY A 29 ? ? -145.90 2 30 SER A 28 ? ? GLY A 29 ? ? -149.33 # loop_ _pdbx_unobs_or_zero_occ_atoms.id _pdbx_unobs_or_zero_occ_atoms.PDB_model_num _pdbx_unobs_or_zero_occ_atoms.polymer_flag _pdbx_unobs_or_zero_occ_atoms.occupancy_flag _pdbx_unobs_or_zero_occ_atoms.auth_asym_id _pdbx_unobs_or_zero_occ_atoms.auth_comp_id _pdbx_unobs_or_zero_occ_atoms.auth_seq_id _pdbx_unobs_or_zero_occ_atoms.PDB_ins_code _pdbx_unobs_or_zero_occ_atoms.auth_atom_id _pdbx_unobs_or_zero_occ_atoms.label_alt_id _pdbx_unobs_or_zero_occ_atoms.label_asym_id _pdbx_unobs_or_zero_occ_atoms.label_comp_id _pdbx_unobs_or_zero_occ_atoms.label_seq_id _pdbx_unobs_or_zero_occ_atoms.label_atom_id 1 1 Y 1 A MET 99 ? O ? A MET 94 O 2 2 Y 1 A MET 99 ? O ? A MET 94 O 3 3 Y 1 A MET 99 ? O ? A MET 94 O 4 4 Y 1 A MET 99 ? O ? A MET 94 O 5 5 Y 1 A MET 99 ? O ? A MET 94 O 6 6 Y 1 A MET 99 ? O ? A MET 94 O 7 7 Y 1 A MET 99 ? O ? A MET 94 O 8 8 Y 1 A MET 99 ? O ? A MET 94 O 9 9 Y 1 A MET 99 ? O ? A MET 94 O 10 10 Y 1 A MET 99 ? O ? A MET 94 O 11 11 Y 1 A MET 99 ? O ? A MET 94 O 12 12 Y 1 A MET 99 ? O ? A MET 94 O 13 13 Y 1 A MET 99 ? O ? A MET 94 O 14 14 Y 1 A MET 99 ? O ? A MET 94 O 15 15 Y 1 A MET 99 ? O ? A MET 94 O 16 16 Y 1 A MET 99 ? O ? A MET 94 O 17 17 Y 1 A MET 99 ? O ? A MET 94 O 18 18 Y 1 A MET 99 ? O ? A MET 94 O 19 19 Y 1 A MET 99 ? O ? A MET 94 O 20 20 Y 1 A MET 99 ? O ? A MET 94 O 21 21 Y 1 A MET 99 ? O ? A MET 94 O 22 22 Y 1 A MET 99 ? O ? A MET 94 O 23 23 Y 1 A MET 99 ? O ? A MET 94 O 24 24 Y 1 A MET 99 ? O ? A MET 94 O 25 25 Y 1 A MET 99 ? O ? A MET 94 O 26 26 Y 1 A MET 99 ? O ? A MET 94 O 27 27 Y 1 A MET 99 ? O ? A MET 94 O 28 28 Y 1 A MET 99 ? O ? A MET 94 O 29 29 Y 1 A MET 99 ? O ? A MET 94 O 30 30 Y 1 A MET 99 ? O ? A MET 94 O #